-
Viral Inactivation System
Ken Carr’s Viral Inactivation System patent, issued on August 16, 2022, applies a high temperature to blood drawn directly from a patient for a short duration of time, destroying HIV, Ebola, and other blood-borne viruses without damaging the blood. The key is short microwave exposure times using microwave heating and radiometric temperature control. The system…
-
Newborn Brain Temperature Monitoring
In partnership with Mass Eye and Ear, Ken Carr developed a 27 gigahertz MMIC radiometric sensor that accurately measures newborn brain temperature with a side-looking dielectric rod transducer to non-invasively and passively measure newborn brain temperature at the target tissue. Similar to Carr’s earlier development of an FDA-approved infiltration detection system to non-invasively monitor and…
-
Early Breast Cancer Detection
MMS’s OncoScan System uses passive, non-invasive microwave radiometry to measure naturally occurring electromagnetic emissions from the human body for the early detection of breast cancer. The body has a core temperature of 37˚C. However, breast temperature, like that of the arms and legs, is a cooler 34.5˚C. Due to the process of angiogenesis, which sends…
